Cabozantinib to Be Featured in 13 Presentations at ESMO 2018 Congress

Cabozantinib will be the subject of 13 presentations at the European Society for Medical Oncology (ESMO) 2018 Congress, which is being held October 19-23, 2018 in Munich, Germany.10/09/2018
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news